Wednesday , December 13 2017
Home / KEEP BUT DO NOT DISPLAY / Alerts / FDA Approves VBLOC Vagal Blocking Therapy for Weight Loss

FDA Approves VBLOC Vagal Blocking Therapy for Weight Loss

VBLOC Therapy is a first-in-class weight loss treatment that addresses the growing global health crises associated with obesity and its co-morbidities, such as diabetes and hypertension. Therapy is delivered by a pacemaker-like device called the Maestro® Rechargeable System controls both hunger and fullness by blocking the primary nerve which regulates the digestive system.